Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Beckebaum

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Transplantation Proceedings|November 14, 2012
Claudin-7 expression in hepatocellular carcinomaE I Brokalaki, F Weber, G C Sotiropoulos, et al.
Endoscopy|November 29, 2012
Use of paclitaxel-eluting balloons for endotherapy of anastomotic strictures following liver transplantationI Kabar, V R Cicinnati, S Beckebaum, et al.
Transplantation Proceedings|September 1, 2009
Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized studyS Beckebaum, C G Klein, G C Sotiropoulos, et al.
European Journal of Medical Research|May 25, 2006
Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patientsJ Li, Uta Dahmen, S Beckebaum, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2009
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipientsS Beckebaum, C Klein, J Varghese, et al.
Transplantation Proceedings|December 23, 2008
"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case reportI Fouzas, G C Sotiropoulos, E P Molmenti, et al.
Transplantation Proceedings|July 15, 2004
Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, X Zhang, et al.
Transplantation Proceedings|December 29, 2004
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, C G Klein, et al.
European Journal of Medical Research|August 5, 2011
Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experienceS Vernadakis, Georgios C Sotiropoulos, E I Brokalaki, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoringV R Cicinnati, Z Yu, C G Klein, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Transplantation Proceedings|November 14, 2012
Claudin-7 expression in hepatocellular carcinomaE I Brokalaki, F Weber, G C Sotiropoulos, et al.
Endoscopy|November 29, 2012
Use of paclitaxel-eluting balloons for endotherapy of anastomotic strictures following liver transplantationI Kabar, V R Cicinnati, S Beckebaum, et al.
Transplantation Proceedings|September 1, 2009
Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized studyS Beckebaum, C G Klein, G C Sotiropoulos, et al.
European Journal of Medical Research|May 25, 2006
Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patientsJ Li, Uta Dahmen, S Beckebaum, et al.
Alimentary Pharmacology & Therapeutics|July 24, 2009
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipientsS Beckebaum, C Klein, J Varghese, et al.
Transplantation Proceedings|December 23, 2008
"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case reportI Fouzas, G C Sotiropoulos, E P Molmenti, et al.
Transplantation Proceedings|July 15, 2004
Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, X Zhang, et al.
Transplantation Proceedings|December 29, 2004
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective studyS Beckebaum, V R Cicinnati, C G Klein, et al.
European Journal of Medical Research|August 5, 2011
Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experienceS Vernadakis, Georgios C Sotiropoulos, E I Brokalaki, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoringV R Cicinnati, Z Yu, C G Klein, et al.
Pageof 4